A detailed history of Apg Asset Management N.V. transactions in Amgen Inc stock. As of the latest transaction made, Apg Asset Management N.V. holds 629,733 shares of AMGN stock, worth $203 Million. This represents 0.33% of its overall portfolio holdings.

Number of Shares
629,733
Previous 563,317 11.79%
Holding current value
$203 Million
Previous $160 Million 22.85%
% of portfolio
0.33%
Previous 0.26%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$262.75 - $319.31 $17.5 Million - $21.2 Million
66,416 Added 11.79%
629,733 $197 Million
Q1 2024

May 14, 2024

SELL
$268.87 - $324.56 $7.25 Million - $8.75 Million
-26,965 Reduced 4.57%
563,317 $160 Million
Q4 2023

Feb 13, 2024

SELL
$255.7 - $288.46 $8.08 Million - $9.11 Million
-31,585 Reduced 5.08%
590,282 $170 Million
Q3 2023

Nov 14, 2023

SELL
$218.65 - $271.46 $18.2 Million - $22.6 Million
-83,198 Reduced 11.8%
621,867 $167 Million
Q2 2023

Aug 14, 2023

BUY
$214.27 - $253.37 $8.24 Million - $9.74 Million
38,456 Added 5.77%
705,065 $157 Million
Q1 2023

May 12, 2023

SELL
$225.79 - $275.2 $25.5 Million - $31.1 Million
-112,931 Reduced 14.49%
666,609 $161 Million
Q4 2022

Feb 14, 2023

BUY
$229.03 - $291.01 $115 Million - $146 Million
500,577 Added 179.44%
779,540 $205 Million
Q3 2022

Nov 14, 2022

SELL
$224.46 - $253.15 $9.42 Million - $10.6 Million
-41,956 Reduced 13.07%
278,963 $64.2 Million
Q2 2022

Aug 12, 2022

BUY
$230.71 - $256.74 $21.8 Million - $24.2 Million
94,364 Added 41.65%
320,919 $74.7 Million
Q1 2022

May 12, 2022

SELL
$219.27 - $242.57 $16.3 Million - $18 Million
-74,333 Reduced 24.7%
226,555 $49.2 Million
Q4 2021

Feb 11, 2022

BUY
$198.88 - $227.6 $9.76 Million - $11.2 Million
49,058 Added 19.48%
300,888 $59.5 Million
Q3 2021

Nov 15, 2021

SELL
$212.27 - $248.7 $8.64 Million - $10.1 Million
-40,700 Reduced 13.91%
251,830 $46.2 Million
Q2 2021

Aug 13, 2021

SELL
$233.58 - $259.14 $14.5 Million - $16.1 Million
-62,065 Reduced 17.5%
292,530 $60.1 Million
Q1 2021

May 14, 2021

SELL
$221.91 - $258.6 $49.1 Million - $57.3 Million
-221,427 Reduced 38.44%
354,595 $75.1 Million
Q4 2020

Feb 12, 2021

SELL
$216.38 - $257.67 $32.3 Million - $38.4 Million
-149,116 Reduced 20.56%
576,022 $108 Million
Q3 2020

Nov 12, 2020

SELL
$234.65 - $260.95 $27.5 Million - $30.5 Million
-116,990 Reduced 13.89%
725,138 $157 Million
Q2 2020

Aug 14, 2020

BUY
$197.81 - $242.74 $21.7 Million - $26.7 Million
109,823 Added 15.0%
842,128 $177 Million
Q1 2020

May 15, 2020

SELL
$182.24 - $241.7 $184 Million - $244 Million
-1,009,321 Reduced 57.95%
732,305 $148 Million
Q1 2020

May 14, 2020

BUY
$182.24 - $241.7 $238 Million - $315 Million
1,304,921 Added 298.81%
1,741,626 $295 Million
Q4 2019

Feb 13, 2020

BUY
$189.21 - $243.2 $37 Million - $47.5 Million
195,500 Added 81.05%
436,705 $93.8 Million
Q3 2019

Nov 08, 2019

SELL
$174.11 - $208.62 $166 Million - $199 Million
-953,021 Reduced 79.8%
241,205 $42.8 Million
Q2 2019

Aug 13, 2019

SELL
$166.7 - $195.41 $91.3 Million - $107 Million
-547,400 Reduced 31.43%
1,194,226 $193 Million
Q1 2019

May 14, 2019

SELL
$180.87 - $203.88 $25.6 Million - $28.9 Million
-141,600 Reduced 7.52%
1,741,626 $295 Million
Q4 2018

Feb 13, 2019

BUY
$178.4 - $208.25 $4.94 Million - $5.77 Million
27,700 Added 1.49%
1,883,226 $321 Million
Q3 2018

Nov 09, 2018

BUY
$185.29 - $208.89 $870,863 - $981,782
4,700 Added 0.25%
1,855,526 $331 Million
Q2 2018

Aug 13, 2018

SELL
$166.05 - $186.51 $10.4 Million - $11.7 Million
-62,900 Reduced 3.29%
1,850,826 $293 Million
Q1 2018

May 14, 2018

SELL
$169.43 - $198.0 $6.01 Million - $7.03 Million
-35,500 Reduced 1.82%
1,913,726 $265 Million
Q4 2017

Jan 24, 2018

BUY
$168.79 - $188.59 $56.5 Million - $63.1 Million
334,454 Added 20.71%
1,949,226 $282 Million
Q3 2017

Oct 19, 2017

BUY
$167.29 - $191.0 $270 Million - $308 Million
1,614,772
1,614,772 $301 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $172B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Apg Asset Management N.V. Portfolio

Follow Apg Asset Management N.V. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Apg Asset Management N.V., based on Form 13F filings with the SEC.

News

Stay updated on Apg Asset Management N.V. with notifications on news.